900P Notch inhibitor AL101 prior to surgery in patients (pts) with Notch1 activated adenoid cystic carcinoma (ACC): Safety and efficacy in a window of opportunity study.

Saved in:
Bibliographic Details
Title: 900P Notch inhibitor AL101 prior to surgery in patients (pts) with Notch1 activated adenoid cystic carcinoma (ACC): Safety and efficacy in a window of opportunity study.
Authors: Ferrarotto, R.1 (AUTHOR), McGrail, D.2 (AUTHOR), Mitani, Y.3 (AUTHOR), Santos, E.1 (AUTHOR), Johnson, F.1 (AUTHOR), Chen, M.4 (AUTHOR), Li, K.5 (AUTHOR), Lin, S-Y.6 (AUTHOR), Frank, S.7 (AUTHOR), Lee, J.J.7 (AUTHOR), Williams, M.8 (AUTHOR), Esmaeli, B.9 (AUTHOR), El-Naggar, A.3 (AUTHOR), Hanna, E.10 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS636-S636. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.961